With patient welfare hanging in the balance, product failure is not an option in healthcare. Applying engineering simulation throughout development can make all the difference in meeting safety standards and product deadlines.
When you build reliability into the design process, it improves compliance with tightening FDA regulations — and saves lives. Since clinical testing can’t address every possible situation, medical device companies adopt engineering simulation (in silico testing) to systematically identify and resolve worst-case scenarios.
With a focus on aging and pathologies that affect a small population, the market demands new therapies, far faster than treatments can become available. To deliver medical innovation faster without compromising reliability, healthcare companies adopt a virtual human laboratory approach to tackle the challenges of pre-clinical testing.
Successful companies adopt these initiatives to arrive at affordable, profitable healthcare products and processes — affordable for patient access; profitable so companies can find even more innovative solutions. By methodically investigating possible solutions, early in the process via a virtual environment, researchers can cost-effectively select the most innovative and reliable alternatives.
The greatest opportunities for growth are in emerging markets — which offer the largest supply of future biomedical engineers. Globalizing healthcare combines customization of existing solutions to local needs and teamwork involving people from different regions, cultures and backgrounds — and, therefore, requires a collaborative simulation environment.